Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MAMA | FLO |
|---|---|---|
| Price | $12.86 | $5.84 |
| Change today | ▲ 1.02% | ▲ 1.74% |
| Market cap | $606.32M | $1.24B |
| Return, 3 months | -29.2% | -26.2% |
| Return, year to date | -4.7% | -42.8% |
| Return, 1 year | +20.8% | -49.4% |
| P/E (TTM) | 75.6 | 22.5 |
| P/B | 3.6 | 0.9 |
| P/E percentile vs own 5y | 69th | 38th |
| Dividend yield | – | 14.86% |
| Revenue growth (YoY, latest qtr) | +55.0% | -4.0% |
| Net profit growth (YoY) | +100.9% | -30.3% |
| Gross margin | 24.3% | 48.6% |
| Operating margin | 4.5% | 5.5% |
| Net margin | 3.5% | 1.1% |
| Return on equity | 7.5% | 4.0% |
| Analyst target vs. price | +77.3% | -5.8% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 35 | 42 |
| 30-day volatility | 58.3% | 27.2% |
| Max drawdown, 1 year | -38.4% | -54.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
